Nachrichten zur Biogen Inc. Aktie

Biogens Q2 Earnings Beat, New Drugs Drive Sales, 2026 Guidance Raised

Biogen tops Q2 earnings and revenue estimates as growth drugs fuel sales, offset MS declines, and support a higher 2026…

Stocks making the biggest moves premarket: Biogen, Vertiv, GE HealthCare, Generac & more

These are the stocks posting the largest moves premarket.…

Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026

Stockholm, Sweden, July 29, 2026 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the preliminary global…

Can These 5 Biotech Stocks Beat Wall Streets Q2 Estimates?

Biotech earnings take center stage as Viking, Biogen, Bristol Myers, Regeneron and AbbVie prepare to report Q2 2026 results.…

The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals

HRMY, ACAD, BIIB, INSM and AGIO are set to report Q2 results, with positive Earnings ESPs suggesting potential earnings surprises.…

Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?

Harmony Biosciences, Acadia, Biogen, Insmed and Agios show positive Earnings ESPs ahead of Q2 results, setting up closely watched earnings…

Biogen Aktie vor dem Zahlen-Check: Rezepttrends treiben neue Kursfantasie

Bad Marienberg (www.aktiencheck.de) - Guggenheim setzt bei der Biogen-Aktie ein deutliches Zeichen: Analyst Yatin Suneja hebt das Kursziel auf 280…

Biogen Shares Decline After Detailed Diranersen Alzheimers Study Data

BIIBs Alzheimers drug data presentation reaffirms a phase II setback as investors weigh plans to advance diranersen in phase III…

Biogen Inc. (BIIB) Presents at Alzheimers Association International Conference (AAIC Meeting) 2026 - Slideshow

…

Biogen Inc. (BIIB) Presents at Alzheimers Association International Conference (AAIC Meeting) 2026 Transcript

…

Biogen: Alzheimer-Hoffnung lebt - Aktie bricht dennoch weg

Auf der diesjährigen Alzheimers Association International Conference (AAIC) in London hat der Biotech-Gigant Biogen richtungsweisende Daten zum Hoffnungsträger Diranersen (BIIB080)…

New drug data could lift shares of this biotechnology stock, Truist says

Biogen could see more upside if it publishes positive results from recent trials linked to kidney and Alzheimers treatments, Truist…

Here are Mondays biggest analyst calls: Nvidia, SpaceX, Tesla, Apple, Netflix, Deckers, Biogen, Nio & more

Here are Mondays biggest calls on Wall Street.…

Why Biogen (BIIB) is Poised to Beat Earnings Estimates Again

Biogen (BIIB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Biogen Is Paying $1 Billion for a Company That Wont Say What It Makes. Heres Why Thats Actually Good News for BIIB Investors.

This could be a key move for future growth.…

Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout

BIIB is set to acquire RayThera for up to $1 billion, adding anti-inflammatory candidates that could expand its immunology pipeline…

Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.

Acquisition adds multiple immunology assets to Biogen’s portfolio, including a lead asset poised to enter Phase 1 development Acquisition adds…

Biogen Aktie: Needham zündet die nächste Kursfantasie!

Bad Marienberg (www.aktiencheck.de) - Biogen: Needham hebt den Daumen - Rating "buy" statt "hold" Biogen Inc. (ISIN: US09062X1037, WKN: 789617,…

Why Is Biogen (BIIB) Up 3.8% Since Last Earnings Report?

Biogen (BIIB) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Biogen Aktie vor neuem Schub? Experten begeistert von Lupus- und Alzheimer-Daten

Toronto (www.aktiencheck.de) - Biogen-Aktienanalyse von RBC Capital Markets:Die Analysten von RBC Capital haben das Kursziel für die Aktie von Biogen…

Denali Stock Dips as Biogen-Partnered Parkinsons Disease Study Fails

DNLI sinks after BIIB122 failed a mid-stage Parkinsons study, prompting Denali and Biogen to halt development in idiopathic cases.…

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease

CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB)…

Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout

Immunic Inc (NASDAQ:IMUX, FRA:10VA), a late-stage biotechnology company developing oral therapies for neurologic diseases, said it has appointed...…

Biogen Aktie: Kurszielanhebung trotz Rückschlag bei Alzheimer-Studie

Minneapolis (www.aktiencheck.de) - Biogen-Aktienanalyse von Piper Sandler:Piper Sandler habe das Kursziel für die Aktie von Biogen Inc. (ISIN: US09062X1037, WKN:…

Goldman Sachs sets new Biogen stock price target on bold Alzheimers bet

Biogen (NASDAQ: BIIB) has had a rocky few years. Its multiple sclerosis franchise has been bleeding market share to generics…

Biogen: Apellis Acquisition, Alzheimers Fail Sums Up Mixed Investment Opportunity

Biogen Inc. upgraded to Hold: Apellis deal adds revenue, MS stable but pipeline delays persist. Click for this updated look…

Biogen advances Alzheimers drug to late-stage trial despite disappointing data

Biogen said signals suggest the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.…

Stocks making the biggest moves premarket: Versant, Biogen, Bullish, Cisco and more

These are the stocks posting the largest moves in the premarket.…

Biogen stock jumps 10% on positive phase 2 diranersen data for Alzheimer’s

Biogen stock jumps 10% on positive phase 2 diranersen data for Alzheimer’s…

Is Biogen Inc. (BIIB) one of the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen?

Biogen Inc. (NASDAQ:BIIB) is the Best Biotech Stock. On April 20, 2026, Reuters reported that Biogen Inc. (NASDAQ:BIIB) had agreed…

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB)…

dpa-AFX ProFeed